Santhera Announces Closing of Exclusive North America Licens

Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone

Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , China , Pratteln , Switzerland General , Switzerland , Highbridge , Somerset , United Kingdom , Germany , Italy , United States , Spain , Swiss , America , Dario Eklund , Eva Kalias , Head Investor Relations Communications , America To Catalyst Pharmaceuticals , Santhera Pharmaceuticals Holding , Life Science Alliance , European Medicines Agency , Chiesi Group , Nasdaq , Regulatory Agency , Catalyst Pharmaceuticals Inc , Santhera Pharmaceuticals , North America , Catalyst Pharmaceuticals , Highbridge Capital , Chief Executive Officer , Hart Scott Rodino Antitrust Improvements , Orphan Drug , Fast Track , Rare Pediatric Disease , Promising Innovative Medicine , Grants Exclusive North America License , Deal Valued , Proc Natl Acad Sci United States , United Kingdom Medicines , Head Investor Relations ,